wegovy a glp 1 GLP-1 weight loss drugs may be misused by patients with eating disorders: Study How GLP-1 medications are transforming

These results established cagrilintide as a clinically meaningful agent in its own right, while also confirming that its mechanism was distinct enough from existing therapies to warrant combination investigation

The drug is available in both injectable and oral forms

Wegovy (semaglutide) is widely prescribed in the UK to support weight loss through appetite regulation and metabolic control, and many individuals begin to wonder whether they can still donate plasma while using Wegovy without affecting safety or eligibility

Glp-1 Supplement Regional Outlook North America GLP-1 Supplement Market North America: Market Dominance Led by Advanced Pharmacy Retail Infrastructure and Supporting Strong Demand for Protein, Hydration, and Digestive-Support Supplements The North America GLP-1 supplement market accounted for the largest regional share of 41.32% in 2025 due to GLP-1 prescription growth, advanced pharmacy retail infrastructure, and increasing demand for companion metabolic nutrition products